A Clinical Investigational Study of Ankura™ II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm

The objective of this clinical investigational study is to evaluate the safety and efficacy of the Ankura™ II AAA, AE Stent Graft System and the large-size Ankura™ II IE Stent Graft System (i.e., IE stent grafts with distal diameters of 24, 26, and 28 mm) for endovascular treatment of abdominal aortic aneurysm in patients with infrarenal abdominal aortic aneurysm who are suitable for endovascular intervention. The primary safety endpoint is the incidence of major adverse events within 30 days after the procedure. The primary efficacy endpoint is the 12-month treatment success rate.

NCT Number	NCT07754240
Lead Sponsor	Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions	Abdominal Aortic Aneurysms (AAA)
Enrollment	45 participants
Start Date	2026-09-30
Primary Completion	2028-12-30 (estimated)
Study Completion	2033-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-14